2025国家基本医保药品目录

Core Data - A total of 3,253 drugs will be included, with 1,857 Western medicines and 1,396 traditional Chinese medicines, effective from January 1, 2026. New additions include 114 drugs, while 29 drugs will be removed [1]. Key Content - The new list includes 50 innovative first-class drugs that address gaps in treatments for tumors, rare diseases, chronic diseases, and pediatric medications. Core products from domestic and international pharmaceutical companies such as AstraZeneca, Junshi Bioscience, and Kangfang Biotech are included [2].